Are Dr Agarwals Health Care Ltd latest results good or bad?

Dr Agarwal's Health Care Ltd reported its financial results for Q4 FY26, showcasing notable operational trends. The consolidated net profit reached ₹39.71 crores, reflecting a year-on-year growth of 21.92%. Revenue for the quarter was ₹564.11 crores, marking a 22.57% increase compared to the same period last year, and a sequential growth of 6.46% from the previous quarter. This revenue growth outpaced the average growth rate of the hospital sector, indicating successful market share gains in the competitive ophthalmology segment. The company's operating margin, excluding other income, stood at 28.62%, which is the highest quarterly margin recorded to date. This margin represents a slight improvement from the previous year's margin of 28.46% and a sequential increase from 27.20% in Q3 FY26. Such performance highlights effective cost management strategies in the face of rising employee costs and raw material expenses. In terms of financial metrics, the operating profit (PBDIT) for Q4 FY26 was ₹161.47 crores, and the PAT margin was reported at 8.86%, slightly down from 9.25% in the corresponding quarter last year. The company also demonstrated improved financial flexibility, with interest expenses decreasing to ₹22.08 crores, enhancing its operating profit to interest coverage ratio to 7.31 times. Overall, Dr Agarwal's Health Care Ltd is navigating a growth trajectory characterized by robust revenue expansion and operational efficiency. However, the company saw an adjustment in its evaluation, reflecting the market's perception of its financial health and operational performance amidst ongoing expansion efforts.